Is IART a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

210 people get IART articles and Market Currents by email alert.

Get email alerts on IART »

FOCUS | PRO | RELATED | TRANSCRIPTS | NEWS & PR

Bear Of The Day: Integra LifeSciences
Zacks Investment Research • Mon, Jun 3
Integra LifeSciences Sputters At Year End, But Is Still Undervalued
Stephen Simpson • Fri, Jan 6, 2012 • 2 Comments
Integra Hitting That Same Ortho Wall
Stephen Simpson • Wed, Nov 2, 2011 • 2 Comments
Integra Recalls Brain Catheters
Zacks Investment Research • Thu, Aug 26, 2010
Integra's Contract Is a Win-Win for Both Companies
Zacks Investment Research • Wed, Dec 23, 2009
Why is the IsoTis/Integra Merger Vote In Jeopardy?
Thomas Kirchner • Wed, Oct 17, 2007 • 1 Comment
Integra LifeSciences Announces Acquisition Of IsoTis For $51 Million
Sara Calabro • Thu, Aug 9, 2007

To learn more about Seeking Alpha Pro, click here.

Stryker Corporation: Specific M&A Predictions
Daniel Lauchheimer • Tue, Feb 19 • 9 Comments
Med-Tech Due For More M&A
Stephen Simpson • Wed, Sep 12, 2012 • 21 Comments
10 Medical Device Stocks Hedge Funds Are Buying Up
Kapitall • Fri, Aug 17, 2012 • 4 Comments
7 Rallying Healthcare Stocks Being Sold Off By Hedge Funds
Kapitall • Fri, May 11, 2012
AxoGen's Got Nerve: Noble Financial Initiates With 'Buy' Rating
Cockrell Group • Thu, Apr 19, 2012
16 Healthcare Stocks Deeply Discounted From Target Price
Kapitall • Thu, Jan 12, 2012 • 2 Comments
Stryker's Guidance Sets Up A Solid 2012
Stephen Simpson • Tue, Jan 10, 2012
18 Healthcare Stocks Undervalued By Target Price
Kapitall • Wed, Nov 9, 2011
5 Earnings Disappointments To Buy Now
Rougemont • Wed, Nov 2, 2011
Accuray Guidance, Backlog Make Stock Look Undervalued
Chris Katje • Sun, Oct 2, 2011 • 1 Comment
Fisher Investments' Healthcare Picks: Large Caps Trumping Small Caps
Zvi Bar • Thu, Jul 14, 2011 • 6 Comments
7 New Healthcare Buys for Kenneth Fisher
Efsinvestment • Mon, Jun 6, 2011 • 4 Comments
Top Medical Equipment Picks by Fund Gurus Concentrated in the Sector
GuruFundPicks • Wed, May 18, 2011
The Best and Worst Medical Device Stocks
Insider Monkey • Wed, Apr 27, 2011 • 7 Comments
Wall Street Breakfast: Must-Know News
SA Editor Yigal Grayeff • Tue, Apr 12, 2011 • 13 Comments
Healthcare Sector: Stronger Than It Looks
Alan Brochstein • Tue, Feb 8, 2011 • 2 Comments
Competitive Technologies: Short Squeeze Coming or Another Leg Down?
David Greene • Wed, Aug 25, 2010 • 29 Comments
Biotech's Slow Week Gets Stirred by a Few Smaller Deals
The Burrill Report • Sun, Aug 15, 2010 • 1 Comment
18 Stocks Showing Unusual Options Volume
Kapitall • Mon, Aug 9, 2010
Competitive Technologies: A Game Changer in Pain Management?
David Greene • Fri, May 14, 2010 • 11 Comments

Integra LifeSciences Holdings Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, May 2
Integra LifeSciences Holdings' CEO Presents at Citi 2013 Global Healthcare Conference (Transcript)
Tue, Feb 26
Integra LifeSciences Holdings Management Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Feb 21
Integra LifeSciences Holdings Corp., Q4 2008 Earnings Call Transcript
Mon, Mar 2, 2009
Integra LifeSciences Holdings Corp. Q3 2008 Earnings Call Transcript
Mon, Nov 10, 2008 • 1 Comment
Integra LifeSciences Holdings Corp Q2 2008 Earnings Call Transcript
Tue, Aug 12, 2008
Integra LifeSciences Holdings Corp. Q4 2007 Earnings Call Transcript
Fri, Feb 29, 2008

Integra LifeSciences to Participate in Investor Conferences in June

GlobeNewswire (May 29, 2013)
Integra LifeSciences to Participate in Investor Conferences in May

GlobeNewswire (May 7, 2013)
Integra LifeSciences Reports First Quarter 2013 Financial Results

GlobeNewswire (May 2, 2013)
Integra LifeSciences Introduces Hollywood(TM) VI Spinal Fusion System

GlobeNewswire (Apr 30, 2013)
Integra LifeSciences Debuts Next-Generation Camino(R) Platform at 2013 American Association of Neurological Surgeons Annual Meeting

GlobeNewswire (Apr 29, 2013)
Integra LifeSciences Launches Integra(R) Compact Cranial Closure System

GlobeNewswire (Apr 29, 2013)
After-Hours Buzz: BBBY, MSFT, HPQ & More

at CNBC.com (Apr 10, 2013)
Integra LifeSciences to Host Its First Quarter 2013 Earnings Results Conference Call on May 2, 2013

GlobeNewswire (Apr 10, 2013)
Integra LifeSciences Issues Voluntary Recall of Certain Products Manufactured in its Anasco, Puerto Rico Facility

GlobeNewswire (Apr 10, 2013)
Integra LifeSciences Integra(R) IPP-ON(R) PIP Fusion System Surpasses 4,000 Hammertoe Correction Implants

GlobeNewswire (Mar 21, 2013)
Integra LifeSciences Expands Its Product Offering for Spinal Deformity

GlobeNewswire (Mar 20, 2013)
Integra LifeSciences Expands Shoulder Product Line With the Introduction of a Proximal Humeral Fracture Plate System

GlobeNewswire (Mar 20, 2013)
Integra LifeSciences Holdings Corporation Announces Changes to Its Board of Directors

GlobeNewswire (Mar 18, 2013)
Integra LifeSciences to Participate in Investor Conferences in March

GlobeNewswire (Mar 5, 2013)
Integra LifeSciences Reports Fourth Quarter 2012 Financial Results

GlobeNewswire (Feb 21, 2013)
Integra LifeSciences to Participate in Investor Conferences in February

GlobeNewswire (Feb 20, 2013)
Integra LifeSciences Receives Warning Letter in Anasco, Puerto Rico, Manufacturing Facility

GlobeNewswire (Feb 19, 2013)
Integra LifeSciences Announces Three-Year Contract With Premier Healthcare Alliance

GlobeNewswire (Jan 31, 2013)
Integra LifeSciences Announces Launch of Integra(R) Flowable Wound Matrix in Europe for Diabetic Foot and Leg Ulcers

GlobeNewswire (Jan 18, 2013)
Integra LifeSciences to Host Its Fourth Quarter 2012 Earnings Results Conference Call on February 21, 2013

GlobeNewswire (Jan 15, 2013)

IART vs. ETF Alternatives

Company Description

Integra, headquartered in Plainsboro, New Jersey, is a world leader in regenerative medicine. We employ approximately 3,000 people around the world who are dedicated to improving patient quality of life through the development, manufacturing and marketing of surgical implants and medical... More

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, May 2, 6:18 AM Integra (IART): Q1 EPS of $0.39 beats by $0.02. Revenue of $196.7M misses by $7.99M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, April 11, 10:59 AM Integra Lifesciences (IART -8%) take a hit this morning after announcing late yesterday that it had issued a voluntary recall of certaing products manufactured in its Anasco, Puerto Rico facility. The company expects the recall to affect its revenues and profits for both Q1 and Q2. It now anticipates its Q1 EPS to come in around $0.30 - $0.40 on revenues in the range of $194M - $197M, versus Street expectations for $0.70 on $204M. For Q2, the company sees revenues of $205M - $211M, versus the $219.52M analysts are expecting. Comment! [Healthcare, On the Move, Earnings]
Wednesday, April 10, 4:21 PM Integra LifeSciences (IART) issues a voluntary recall of certain products manufactured in its Añasco, Puerto Rico facility, specifically its DuraGen Dural Graft Matrix products, have been recalled because there may have been deviations from approved processes in their production. There have been no reports of adverse patient events attributable to the products subject to the recall. Shares -0.4% AH. Comment! [Healthcare]
Wednesday, March 20, 2:11 PM Integra LifeSciences (IART -1.3%) catches a bout of volatility today, now trading down after saying it's expanding its range of products to treat spinal deformity by adding a second cobalt chrome rod for its Daytona and Malibu Spinal systems, which provides additional strength and stiffness over the existing chrome rod. The new offering expected to have a controlled market release in Q3. Comment! [Healthcare, On the Move]
Thursday, February 21, 6:04 AM Integra (IART): Q4 EPS of $0.78 beats by $0.02. Revenue of $214.4M (+5.4% Y/Y) misses by $1.5M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Wednesday, October 24, 2012, 6:11 AM Integra LifeSciences (IART): Q3 EPS of $0.85 beats by $0.09. Revenue of $210M (+4% Y/Y) in-line. (PR) Comment! [Earnings, Tech]
Thursday, July 26, 2012, 10:11 AM Integra (IART): Q2 EPS of $0.74 beats by $0.05. Revenue of $210.2M (+8.7% Y/Y) beats by $4.79M. (PR) Comment! [Earnings, Tech]
Thursday, February 23, 2012, 8:44 AM Integra LifeSciences (IART): Q4 EPS of $0.72 beats by $0.17. Revenue of $203.5M (+4.8% Y/Y) in-line. (PR) Comment! [Earnings]
Thursday, January 5, 2012, 4:53 PM Integra LifeSciences (IART) cuts Q4 guidance, now expecting total revenues to be around $202M - $203M. The company attributes the revenue shortfall to inventory reduction initiatives by its instruments distributors and weaker than expected sales of its domestic extremity reconstruction products. Additionally, the company also acknowledges receiving a warning letter from the FDA following the inspection of its Plainsboro facility. Shares are halted AH. Comment! [Healthcare, On the Move]
Wednesday, December 21, 2011, 11:52 AM Integra LifeSciences (IART -1.7%) trades lower after the company announces its CEO Stuart Essig will step down next year and its COO Peter Arduini will become his successor. Comment! [Healthcare]
Monday, October 31, 2011, 10:22 AM Medical device maker Integra LifeSciences (IART -6.2%) sells off after reporting Q3 revenue of $202.2M (+8% Y/Y) and EPS of $0.77; the latter was in-line, but the former missed by $1.95M. Integra, which says it's facing a "challenging selling environment," is also lowering its 2011 EPS guidance range to $2.88-$2.96, from a prior range of $2.92-$3.02. Comment! [Healthcare, Earnings, On the Move]
Tuesday, April 12, 2011, 7:44 AM The FDA authorizes the marketing of three spinal implants from Integra (IART). The three devices are in limited commercial release and set for full release later this year. (PR) Comment! [Healthcare]
Thursday, October 28, 2010, 6:40 AM Integra LifeSciences (IART): Q3 EPS of $0.73 beats by $0.07. Revenue of $187M (+8.3%) vs. $183M. Shares -0.7% premarket. (PR) Comment!
Thursday, October 28, 2010, 12:05 AM Notable earnings before Thursday's open: ABX, AN, ART, AVA, AVP, AVT, BC, BCO, BDC, BEN, BG, BLL, BMS, BRKR, BX, CAH, CCE, CELG, CL, CLI, CLP, CLS, CME, CMS, CNP, CPO, CRI, CRR, DBD, DLX, DOW, DUK, EE, EK, EQT, EXP, FAF, FO, GT, GTI, HEP, HOT, HS, HSC, IART, ICON, IDA, IMAX, IRM, KBR, KMT, LANC, LEA, LINE, LKQX, LLL, LVLT, LZ, MCO, MDU, MJN, MMM, MOT, NBL, NIHD, NXY, OCR, OMX, ORI, OSK, PCH, PNW, POR, POT, PPL, PSSI, PTEN, RGS, RTN, SHAW, STRA, SYNT, TDY, TE, TEL, TEN, TKR, TLCR, TRI, UTHR, VCI, WMB, XEL, XRAY, ZMH Comment!

ltfinger
New Upgrades (5/2/13): $APD, $AFSI, $ATHN, $ATW, $CNX, $DIN, $DRQ, $DNKN, $ESC, $ENR, $EZPW, $FBHS, $GIL, $GPI, $HCI, $IART, $PWR, $TPC
May 3, 8:56 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Cockrell Group
$IART is scheduled to report Q4 results before the open February 21. Guidance is $828-838M with adjusted EPS of $3.04-$3.09.
Feb 21, 8:18 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Cockrell Group
Integra Lifesciences (IART) reported 1Q2012 EPS of $0.71 vs. the consensus of $0.60. http://bit.ly/IsAfQz
4/26/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

John Cofran
out of $IART with 2.75% gain
11/3/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

EquityClock
IART is entering period of seasonal strength. Technicals and fundamentals justify a 12% gain. http://bit.ly/aUQUgY
6/3/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

IART Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation